Why nemtabrutinib works so well in CLL, NHL | OSUCCC - James 

Jennifer Woyach, MD, a hematologist-oncologist at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), explains that nemtabrutinib looks promising in the treatment of CLL and NHL because of its effectiveness and safety. Nemtabrutinib produces remissions in CLL and NHL and it's well tolerated by most patients.
#nemtabrutinib #cancertreatment
Learn more about CLL at go.osu.edu/Jam... and NHL at go.osu.edu/Jam...